ClinConnect ClinConnect Logo
Search / Trial NCT00819429

Supplements and Social Skills Intervention Study

Launched by NATIONAL HEALTHCARE GROUP, SINGAPORE · Jan 8, 2009

Trial Information

Current as of May 29, 2025

Completed

Keywords

Attention Deficit Hyperactivity Disorder Conduct Disorder Oppositional Defiant Disorder Omega 3 Supplements Social Skills Training Dietary Intake Aggression Nutrition Disruptive Behaviors Disorder

ClinConnect Summary

Serious adult crime and violence is a social problem despite decades of intervention and prevention work. One of the reasons for the world-wide failure to prevent this problem stems from (a) a failure to tackle the biological component of the crime/ violence equation in treatment programs, and (b) the failure to tackle this adult condition in its formative childhood origins. Investing modest resources in early biosocial prevention programs could yield enormous long-term financial dividends in terms of the saved legal, medical, social, and psychological costs resulting from adult crime. This...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects between ages 7 and 16 years
  • Subjects who fulfils all criteria for a DSM-IV diagnosis of ADHD, conduct disorder, or oppositional defiant disorder
  • Subjects with willingness to participate in a randomized, double-blind controlled trial,
  • Subjects with complete with written, informed parental consent and assent
  • Subjects with IQ of 70 or more
  • Exclusion Criteria:
  • Subjects who have IQ in the below 70
  • Subjects who are younger than 7 years old
  • Those without written parental consent will not be allowed to participate in the study
  • Those with brain pathology such as serious head injury, epilepsy will be excluded

About National Healthcare Group, Singapore

The National Healthcare Group (NHG) in Singapore is a leading integrated healthcare provider committed to delivering high-quality, patient-centered care through its extensive network of hospitals, polyclinics, and specialty care services. As a prominent sponsor of clinical trials, NHG is dedicated to advancing medical research and innovation, fostering collaboration between healthcare professionals and researchers to enhance treatment options and improve health outcomes. The organization emphasizes rigorous ethical standards and scientific integrity, ensuring that all trials contribute valuable insights to the global medical community while prioritizing patient safety and well-being.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Daniel SS Fung, A/Prof

Principal Investigator

Institute of Mental Health, Singapore

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials